(Use Google Chrome or Mozilla Firefox to secure your place)

Transform your clinical operation in just 3 days!

In the race to submission, every moment of clinical development counts. In this online summit, we'll show you how to beat the odds and improve the way your next clinical trial performs. Over three days, we'll bring together industry experts to help you forecast, manage and operate innovative and efficient trials.

image

Optimize your current processes

With only 1 in 10 clinical trials successfully leading to regulatory approval, it is crucial to set up each trial for success. Over the course of the event, we'll cover:
  • How to forecast and mitigate key risks
  • How to track performance and make crucial improvements
  • How to engage and retain your patients

image

Prepare for the future of clinical trials

New innovation is on the horizon for clinical trials. To take advantage of the opportunities this brings, careful planning is needed. Our experts will share:
  • How to use technology to improve the patient experience
  • How to gain new insights from your site data
  • How to use data to spot hidden patterns and trends

Find out how to:

globe image

Effectively manage the full scope of your clinical trials

globe image

Drive collaboration between stakeholders and patients

iphone image

Implement new technology and gain value from your data

Event Sponsors

Day 1 - 12th November 


The success of a clinical trial rests on effective trial management. Over the course of Day 1, find out how to improve the efficiency of complex trials, gain real value from your trial data and mitigate pressing risks.




Risk based monitoring is essential for subject safety, data quality and operational efficiency. Find out how to assess and mitigate clinical risk and stay on target using a systematic, prioritized risk approach.

SPEAKERS: Buz Hilman, Associate Director, Product Development & Supply, Janssen & Reginald Hooks, Associate Director, Clinical 


For certain therapeutic areas, the clinical trial process is highly complex and unpredictable. We share strategies from vaccine and rare disease trials to show you how to set up your trials for success.


SPEAKERS: Thomas Lingelbach, CEO, Valneva & Daniel de Boer, CEO, ProQR Therapeutics

Day 2 - 13th November


New technology offers opportunities to change the way clinical trials are managed, operated and reviewed. On Day 2, we'll look at how to turn data into agile insights, where to leverage new technology and how to use data to drive new developments


Patient-facing technology allows for richer and more frequent data collection, without increased patient burden. We analyze the pace of adoption, review applications and share how to scale up a pilot program successfully.

SPEAKER: Matthew Moyer, Director of Clinical Supply Technology, Merck


Even if a trial does not lead to approval, a wealth of data has been gathered that could prove invaluable to future developments. We share how to best use this data to guide future drug developments and clinical strategy.

SPEAKER: Preston Klassen, EVP and Head of R&D, Arena Pharma

Day 3 - 14th November


Successful clinical development is underpinned by strong collaboration from all partners and an engaged patient base. During Day 3, we'll share how to spot key data trends, use clinical trials to improve overall R&D efficiency and fully engage your patient communities.


R&D efficiency levels are dropping year on year, leading to declining ROI. Find out how to overcome clinical process challenges to gain new levels of operational efficiency.


SPEAKER: Andrew Garrett, EVP, Scientific Operations, ICON

4pm - 4:45pm [GMT]
Accessible trials: Communication models to engage hard to reach patient communities


Many companies are struggling to reach and retain the right patients for their clinical trials. We offer new communication models and strategies to connect you with the right patients at the right time.

SPEAKER: Keri McDonough, Leader for Advocacy and Patient Relations at Syneos Health

Featured Speakers

Thomas Lingelbach

Thomas Lingelbach

CEO

Valneva

Preston Klassen

Preston Klassen

EVP and Head of Research & Development

Arena Pharma

Daniel de Boer

Daniel de Boer

CEO

ProQR Therapeutics

Matthew Moyer

Matthew Moyer

Director of Clinical Supply Technology

Merck

Andrew Garrett

Andrew Garrett

Executive Vice President of Scientific Operations

ICON

Buz Hilman

Buz Hilman

Associate Director, Product Development & Supply

Janssen

Reginald Hooks

Reginald Hooks

Associate Director, Clinical Operations

Oncolytics Biotech